Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» rheumatoid arthritis
rheumatoid arthritis
Eli Lilly and Incyte say FDA failed to approve their rheumatoid arthritis drug
Marketwatch
Fri, 04/14/17 - 10:48 am
Eli Lilly
Incyte
FDA
rheumatoid arthritis
baricitinib
$5B in Humira sales at stake with Amgen EU approval
BioPharma Dive
Sat, 03/25/17 - 12:18 pm
Humira
Amgen
Europe
rheumatoid arthritis
Amgevita
biosimiliars
Pfizer Announces Approval By The China Food And Drug Administration Of XELJANZ®, The First Oral JAK Inhibitor For Adult Patients With Moderately To Severely Active Rheumatoid Arthritis
Yahoo
Thu, 03/16/17 - 09:45 am
Pfizer
China
Xeljanz
rheumatoid arthritis
Pfizer Reports Top-Line Results for Rheumatoid Arthritis Treatment Study
Yahoo/GuruFocus
Mon, 02/27/17 - 10:11 pm
Pfizer
rheumatoid arthritis
Xeljanz
Amgen Signs Value-Based Deal for Enbrel (AMGN)
Investopedia
Thu, 02/23/17 - 09:39 pm
Amgen
Enbrel
rheumatoid arthritis
Pfizer + relationship expert = RA connection?
BioPharma Dive
Fri, 02/17/17 - 09:55 am
Pfizer
rheumatoid arthritis
Xeljanz
Pfizer says rheumatoid arthritis drug is comparable to Humira as combination treatment but not alone
Marketwatch
Thu, 02/16/17 - 03:13 pm
Pfizer
Xeljanz
AbbVie
Humira
rheumatoid arthritis
Three kinds of drugs, like those that treat RA and diabetes, drive increase in spending
Medical Marketing and Media
Wed, 02/8/17 - 09:24 pm
drug spending
diabetes
rheumatoid arthritis
oncology
Pfizer's New Biosimilar Is Off and Running
Motley Fool
Sat, 02/4/17 - 10:00 am
Pfizer
biosimilars
Remicade
JNJ
Inflectra
rheumatoid arthritis
Novartis says court battle will delay its Enbrel copy until 2018 at least
Yahoo/Reuters
Wed, 01/25/17 - 09:58 am
Novartis
Enbrel
patents
Erelzi
Amgen
biosimilars
rheumatoid arthritis
Barictinib FDA Delay Only A 'Short-Term Setback' For Eli Lilly, Says Credit Suisse
Yahoo/Benzinga
Tue, 01/17/17 - 10:18 pm
Eli Lilly
baricitinib
rheumatoid arthritis
FDA delays decision on Lilly and Incyte's arthritis drug
BioPharma Dive
Tue, 01/17/17 - 11:04 am
FDA
Eli Lilly
Incyte
rheumatoid arthritis
baricitinib
Migraine drugs may repeat rheumatoid arthritis success
Yahoo/Reuters
Sat, 12/24/16 - 12:19 pm
migraines
rheumatoid arthritis
biologics
Pfizer’s Xeljanz Expected to See Strong Growth Trends in 2016
Market Realist
Thu, 11/17/16 - 04:52 pm
Pfizer
Xeljanz
rheumatoid arthritis
J&J, GSK stumble coming out of the gate with mixed PhIII rheumatoid arthritis data for sirukumab
Endpoints
Sun, 11/13/16 - 12:00 pm
JNJ
GSK
rheumatoid arthritis
sirukumab
AbbVie
Humira
Boehringer flags PhIII success for another Humira knockoff, setting up a crowded field of cheaper rivals — eventually
Endpoints
Wed, 10/26/16 - 09:16 pm
Boehringer Ingelheim
Humira
BI 695501
AbbVie
rheumatoid arthritis
UCB’s Cimzia AutoClicks pen hits the U.K. market
Mass Device
Wed, 10/26/16 - 08:54 am
UCB Pharma
Cimzia
UK
devices
rheumatoid arthritis
Cimzia AutoClick
No surprise: AbbVie turns cold shoulder to a messy rheumatoid arthritis partnership with Ablynx
Endpoints
Thu, 10/20/16 - 09:34 am
AbbVie
rheumatoid arthritis
Ablynx
vobarilizumab
J&J optimistic in spite of biosimilar threat
BioPharma Dive
Wed, 10/19/16 - 10:39 am
JNJ
biosimilars
Remicade
Pfizer
rheumatoid arthritis
Pfizer set to start shipping Remicade biosimilar next month
Yahoo/Reuters
Tue, 10/18/16 - 12:03 am
Pfizer
Remicade
biosimilars
Inflectra
JNJ
rheumatoid arthritis
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »